A Comprehensive Review about the Molecular Structure of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Insights into Natural Products against COVID-19

dc.AffiliationOctober University for modern sciences and Arts (MSA) 
dc.contributor.authorSaied, Essa M
dc.contributor.authorEl-Maradny, Yousra A
dc.contributor.authorOsman, Alaa A
dc.contributor.authorDarwish, Amira M. G
dc.contributor.authorAbo Nahas, Hebatallah H
dc.contributor.authorNiedbała, Gniewko
dc.contributor.authorPiekutowska, Magdalena
dc.contributor.authorAbdel-Rahman, Mohamed A
dc.contributor.authorBalbool, Bassem A
dc.contributor.authorAbdel-Azeem, Ahmed M
dc.date.accessioned2021-11-05T11:49:32Z
dc.date.available2021-11-05T11:49:32Z
dc.date.issued21/10/2021
dc.descriptionScopusen_US
dc.description.abstractIn 2019, the world suffered from the emergence of COVID-19 infection, one of the most difficult pandemics in recent history. Millions of confirmed deaths from this pandemic have been reported worldwide. This disaster was caused by SARS-CoV-2, which is the last discovered member of the family of Coronaviridae. Various studies have shown that natural compounds have effective antiviral properties against coronaviruses by inhibiting multiple viral targets, including spike proteins and viral enzymes. This review presents the classification and a detailed explanation of the SARS- CoV-2 molecular characteristics and structure–function relationships. We present all currently available crystal structures of different SARS-CoV-2 proteins and emphasized on the crystal structure of different virus proteins and the binding modes of their ligands. This review also discusses the various therapeutic approaches for COVID-19 treatment and available vaccinations. In addition, we highlight and compare the existing data about natural compounds extracted from algae, fungi, plants, and scorpion venom that were used as antiviral agents against SARS-CoV-2 infection. Moreover, we discuss the repurposing of select approved therapeutic agents that have been used in the treatment of other viruses.en_US
dc.identifier.doihttps://doi.org/10.3390/pharmaceutics13111759
dc.identifier.otherhttps://doi.org/10.3390/pharmaceutics13111759
dc.identifier.urihttp://repository.msa.edu.eg/xmlui/handle/123456789/4762
dc.language.isoen_USen_US
dc.publisherMDPIen_US
dc.relation.ispartofseriesPharmaceutics;2021, 13, 1759.
dc.subjectcoronavirusen_US
dc.subjectSARS-CoV-2en_US
dc.subjectvirus lifecycleen_US
dc.subjectCOVID-19en_US
dc.subjectvirus detectionen_US
dc.subjectmolecular structureen_US
dc.subjectvaccinesen_US
dc.subjecttherapeutic approachen_US
dc.subjectnatural productsen_US
dc.subjectantiviralsen_US
dc.subjectantioxidantsen_US
dc.titleA Comprehensive Review about the Molecular Structure of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2): Insights into Natural Products against COVID-19en_US
dc.typeArticleen_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
pharmaceutics-13-01759-v3.pdf
Size:
35.15 MB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
51 B
Format:
Item-specific license agreed upon to submission
Description: